Feilun Cui

408 total citations
29 papers, 250 citations indexed

About

Feilun Cui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Feilun Cui has authored 29 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Feilun Cui's work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Feilun Cui is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Cancer, Lipids, and Metabolism (4 papers). Feilun Cui collaborates with scholars based in China. Feilun Cui's co-authors include Jianpeng Hu, Jian Tan, Yu Fan, Dong Lin, Changfeng Man, Binbin Hu, Yan Chen, Zhipeng Xu, Yu Fan and Liansheng Zhang and has published in prestigious journals such as Frontiers in Immunology, International Journal of Biological Macromolecules and Frontiers in Pharmacology.

In The Last Decade

Feilun Cui

23 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feilun Cui China 9 172 88 70 35 28 29 250
Sansan Chen China 13 190 1.1× 136 1.5× 36 0.5× 68 1.9× 54 1.9× 25 369
Nataly Stylianou Australia 6 179 1.0× 140 1.6× 123 1.8× 102 2.9× 20 0.7× 9 345
Jinfeng Gan China 10 203 1.2× 91 1.0× 47 0.7× 98 2.8× 26 0.9× 21 324
Jianfeng Zhang China 8 182 1.1× 50 0.6× 143 2.0× 33 0.9× 29 1.0× 13 327
Yuanjie Niu China 8 147 0.9× 71 0.8× 58 0.8× 37 1.1× 20 0.7× 12 243
Rongjie Zhao China 9 162 0.9× 102 1.2× 56 0.8× 60 1.7× 13 0.5× 21 279
Miriam Ferrer United States 10 219 1.3× 71 0.8× 25 0.4× 54 1.5× 13 0.5× 14 306
Maria Schubert Germany 8 220 1.3× 170 1.9× 97 1.4× 25 0.7× 17 0.6× 20 390
Laura Cato United States 4 282 1.6× 185 2.1× 43 0.6× 39 1.1× 10 0.4× 5 381
Yuanxi Zhu China 6 152 0.9× 92 1.0× 39 0.6× 148 4.2× 18 0.6× 8 364

Countries citing papers authored by Feilun Cui

Since Specialization
Citations

This map shows the geographic impact of Feilun Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilun Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilun Cui more than expected).

Fields of papers citing papers by Feilun Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feilun Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilun Cui. The network helps show where Feilun Cui may publish in the future.

Co-authorship network of co-authors of Feilun Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Feilun Cui. A scholar is included among the top collaborators of Feilun Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feilun Cui. Feilun Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Luyao, Feilun Cui, Xiangping Chen, et al.. (2025). Examining the causal relationship between hypertension and benign paroxysmal vertigo: a univariate and multivariate Mendelian randomization study. Acta Oto-Laryngologica. 145(5). 400–408.
2.
3.
4.
Liu, Yun, et al.. (2025). circGAPVD1 inhibits the progression of gastric cancer through miR-4424/STK4 axis and encoding GAPVD1-137aa protein. International Journal of Biological Macromolecules. 319(Pt 3). 145408–145408.
5.
6.
Yao, Min, et al.. (2024). Communication molecules (ncRNAs) mediate tumor-associated macrophage polarization and tumor progression. Frontiers in Cell and Developmental Biology. 12. 1289538–1289538. 2 indexed citations
7.
Cao, Jia, et al.. (2024). Helicobacter pylori upregulates circPGD and promotes development of gastric cancer. Journal of Cancer Research and Clinical Oncology. 150(2). 104–104. 5 indexed citations
8.
Xu, Xu, et al.. (2024). Characteristics, clinical significance, and cancer immune interactions of lipid metabolism in prostate cancer. Translational Cancer Research. 13(7). 3575–3588. 1 indexed citations
9.
10.
Cui, Feilun, Yue Qiu, Wei Xu, et al.. (2024). Association between Charlson comorbidity index and survival outcomes in patients with prostate cancer: A meta-analysis. Heliyon. 10(4). e25728–e25728.
11.
Liu, Yun, et al.. (2023). Low Expression of GIGYF1 Inhibits Metastasis, Proliferation, and Promotes Apoptosis and Autophagy of Gastric Cancer Cells. International Journal of Medical Sciences. 20(8). 1038–1045. 6 indexed citations
12.
Cui, Feilun, et al.. (2022). Spindle pole body component 25 in the androgen-induced regression of castration-resistant prostate cancer. Translational Andrology and Urology. 11(4). 519–527. 3 indexed citations
13.
Cui, Feilun, et al.. (2022). Spindle pole body component 25 and platelet-derived growth factor mediate crosstalk between tumor-associated macrophages and prostate cancer cells. Frontiers in Immunology. 13. 907636–907636. 11 indexed citations
14.
Cui, Feilun, et al.. (2021). Calcium‑binding and coiled‑coil domain 2 promotes the proliferation and suppresses apoptosis of prostate cancer cells. Experimental and Therapeutic Medicine. 21(4). 405–405. 4 indexed citations
15.
Cui, Feilun, et al.. (2021). Role of spindle pole body component 25 in neurodegeneration. Annals of Translational Medicine. 9(18). 1432–1432. 7 indexed citations
16.
Cui, Feilun, et al.. (2019). Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer. Oncology Letters. 17(6). 5768–5776. 29 indexed citations
17.
Fan, Yu, Binbin Hu, Changfeng Man, & Feilun Cui. (2018). Erectile dysfunction and risk of cardiovascular and all-cause mortality in the general population: a meta-analysis of cohort studies. World Journal of Urology. 36(10). 1681–1689. 27 indexed citations
18.
Hu, Jianpeng, Zhen Qiu, Liansheng Zhang, & Feilun Cui. (2014). Kallikrein 3 and vitamin D receptor polymorphisms: potentials environmental risk factors for prostate cancer. Diagnostic Pathology. 9(1). 84–84. 15 indexed citations
19.
Lin, Dong, et al.. (2011). The Expression and Clinical Significance of GTP-Binding RAS-Like 3 (ARHI) and MicroRNA 221 and 222 in Prostate Cancer. Journal of International Medical Research. 39(5). 1870–1875. 29 indexed citations
20.
Qiu, Zhen, et al.. (2007). [Suppression of invasion and angiogenesis in human prostate cancer PC-3 cells by adenovirus-mediated co-transfer of PTEN and P27].. PubMed. 13(3). 201–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sansan Chen Breakdown of academic impact, for papers by Nataly Stylianou Breakdown of academic impact, for papers by Jinfeng Gan Breakdown of academic impact, for papers by Jianfeng Zhang Breakdown of academic impact, for papers by Yuanjie Niu Breakdown of academic impact, for papers by Rongjie Zhao Breakdown of academic impact, for papers by Miriam Ferrer Breakdown of academic impact, for papers by Maria Schubert Breakdown of academic impact, for papers by Laura Cato Breakdown of academic impact, for papers by Yuanxi Zhu
Rankless by CCL
2026